| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.007 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.15 | 0.008 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.008 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.009 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.009 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.01 |